|Bid||7.45 x 0|
|Ask||8.00 x 0|
|Day's range||7.65 - 7.70|
|52-week range||6.15 - 13.80|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
NEWPORT BEACH, Calif., March 08, 2023--Evolus reports financial results for the fourth quarter and full year ended December 31, 2022 and provides a business update
NEWPORT BEACH, Calif., February 28, 2023--Evolus announces that members of its management team will be participating in the Barclays Global Healthcare Conference in Miami Beach, Florida.
NEWPORT BEACH, Calif., February 27, 2023--Evolus commences the commercial launch of Nuceiva® in Germany and Austria, and is now available for direct order and delivery to customers.